2019
DOI: 10.1007/s12031-019-01390-0
|View full text |Cite
|
Sign up to set email alerts
|

LMNA-Related Muscular Dystrophy with Clinical Intrafamilial Variability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 11 publications
0
2
0
1
Order By: Relevance
“…It is widely accepted that early diagnosis of LMNA-related muscular diseases is key for appropriate clinical management (Charniot et al, 2003), particularly in L-CMD (Ben Yaou et al, 2021). In addition, clinical familial history and close genotype-phenotype correlation can help clarify the role of genetic variants in onset as well as progression of disease (Cotta et al, 2019;Ben Yaou et al, 2021). Therefore, existence of additional rare genetic modifiers has been suggested as an explanation for clinical phenotype difference observed in families diagnosed with any type of laminopathy (Muntoni et al, 2006;Boudreau et al, 2012;Roncarati et al, 2013) despite no comprehensive genotype-phenotype study.…”
Section: Discussionmentioning
confidence: 99%
“…It is widely accepted that early diagnosis of LMNA-related muscular diseases is key for appropriate clinical management (Charniot et al, 2003), particularly in L-CMD (Ben Yaou et al, 2021). In addition, clinical familial history and close genotype-phenotype correlation can help clarify the role of genetic variants in onset as well as progression of disease (Cotta et al, 2019;Ben Yaou et al, 2021). Therefore, existence of additional rare genetic modifiers has been suggested as an explanation for clinical phenotype difference observed in families diagnosed with any type of laminopathy (Muntoni et al, 2006;Boudreau et al, 2012;Roncarati et al, 2013) despite no comprehensive genotype-phenotype study.…”
Section: Discussionmentioning
confidence: 99%
“…His genetic panel identified two lesions, one in the LMNA gene c.1129C>T (p.Arg377Cys) and another in the SNTA1 gene c.287G>C (p.Gly96Ala). LMNA is a gene that encodes for structural proteins of the nuclear lamina, lamin A and lamin C, and is one of the most common genes associated with dilated cardiomyopathies 7 . Mutations in the LMNA gene have broad presentations, including congenital Emery‐Dreifuss muscular dystrophy and increased risk of malignant ventricular arrhythmias and advanced cardiomyopathies 8,9 .…”
Section: Case Presentationmentioning
confidence: 99%
“…Fonte: Autores.4. Discussão(Achmad et al, 2017;Binder et al, 2020;Blagova et al, 2016;Borch et al, 2022;Brisset et al, 2019;Calame et al, 2021;Carboni et al, 2008;Carboni et al, 2012;Chen et al, 2017;Chiba et al, 2020;Cotta et al, 2019;Coutance et al, 2012;Dai et al, 2020;Dell'Amore et al, 2007;Deymeer et al, 1993;Di Blasi et al, 2000; Douglas et al, 2022; Dumitru et al, 2021;Duras et al, 2022;Ellis et al, 1999;Ellis et al, 2000;Felice et al, 2000;Fidzianska et al, 2010;Finsterer et al, 2015;Fujimoto et al, 1999;Fujita et al, 2005;Ghosh & Milone, 2014; Giuca et al, 2020;Golzio & Chiribiri, 2007;Gossios et al, 2013; Hausmanowa-Petrusewic et al, 2015;Higuchi et al, 2005;Hoeltzenbein et al, 1999;Homma et al, 2018;Hong et al, 2005;Huang et al, 2020; Ichkawa et al, 1997;Ishikawa et al, 2011;Iskandar et al, 2022;Jimenez-Escrig et al, 2012;Kalin et al, 2019; Karst et al, 2009; Kichuk et al, 2002; Köbel et al, 2018; Ki et al, 2022;Kim et al, 2008;Kovalchuk et al, 2021; Lassuthová et al, 2009;Lee et al, 2020;…”
unclassified